MWM
PFE icon

Manske Wealth Management’s Pfizer PFE Stock Holding History

Manske Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
53,019
-705
-1% -$18.4K 0.32% 60
2026
Q1 		$1.51M Buy
53,724
+426
+0.8% +$11.3K 0.42% 51
2025
Q4 		$1.33M Buy
53,298
+2,091
+4% +$52.7K 0.39% 53
2025
Q3 		$1.3M Sell
51,207
-1,428
-3% -$35.2K 0.4% 53
2025
Q2 		$1.28M Buy
52,635
+2,274
+5% +$53K 0.42% 48
2025
Q1 		$1.28M Buy
50,361
+872
+2% +$22.8K 0.48% 46
2024
Q4 		$1.31M Buy
+49,489
New +$1.34M 0.52% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Manske Wealth Management's PFE Position: Q2 2026 in Review

Manske Wealth Management reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $18.4K and leaving 53,019 shares worth $1.28M. The position accounts for 0.32% of the portfolio, ranked #60.

Manske Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.51M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Manske Wealth Management held 53,019 shares of Pfizer worth $1.28M as of Q2 2026.
  • Manske Wealth Management sold 705 Pfizer shares in Q2 2026, an estimated $18.4K.
  • Pfizer made up 0.32% of Manske Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Manske Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Manske Wealth Management's Pfizer position peaked at $1.51M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.